Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 1;4(4):041506.
doi: 10.1063/5.0021554. eCollection 2020 Dec.

Evaluation of current diagnostic methods for COVID-19

Review

Evaluation of current diagnostic methods for COVID-19

Saadet Alpdagtas et al. APL Bioeng. .

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the agent responsible for the coronavirus disease of 2019 (COVID-19), which triggers lung failure, pneumonia, and multi-organ dysfunction. This enveloped, positive sense and single-stranded RNA virus can be transmitted through aerosol droplets, direct and indirect contacts. Thus, SARS-CoV-2 is highly contagious and has reached a pandemic level in a few months. Since COVID-19 has caused numerous human casualties and severe economic loss posing a global threat, the development of readily available, accurate, fast, and cost-effective diagnostic techniques in hospitals and in any places where humans spread the virus is urgently required. COVID-19 can be diagnosed by clinical findings and several laboratory tests. These tests may include virus isolation, nucleic acid-based molecular assays like real-time polymerase chain reactions, antigen or antibody-based immunological assays such as rapid immunochromatographic tests, enzyme-linked immunosorbent assays, immunofluorescence techniques, and indirect fluorescent antibody techniques, electrochemical sensors, etc. However, current methods should be developed by novel approaches for sensitive, specific, and accurate diagnosis of COVID-19 cases to control and prevent this outbreak. Thus, this review will cover an overview and comparison of multiple reports and commercially available kits that include molecular tests, immunoassays, and sensor-based diagnostic methods for diagnosis of COVID-19. The pros and cons of these methods and future perspectives will be thoroughly evaluated and discussed.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Diagnostic periods to detect SARS-CoV-2 infection and the immune response indicating previous exposure to SARS-CoV-2.
FIG. 2.
FIG. 2.
Diagnostic methods for RNA viruses.

References

    1. Lu H., Stratton C. W., and Tang Y. W., J. Med. Virol. 92(4), 401–402 (2020). 10.1002/jmv.25678 - DOI - PMC - PubMed
    1. Sohrabi C., Alsafi Z., O'Neill N., Khan M., Kerwan A., Al-Jabir A., Iosifidis C., and Agha R., Int. J. Surg. 76, 71 (2020). 10.1016/j.ijsu.2020.02.034 - DOI - PMC - PubMed
    1. Hamid S., Mir M. Y., and Rohela G. K., New Microbes New Infect. 35, 100679 (2020). 10.1016/j.nmni.2020.100679 - DOI - PMC - PubMed
    1. Ren L. L., Wang Y. M., Wu Z. Q., Xiang Z. C., Guo L., Xu T., Jiang Y. Z., Xiong Y., Li Y. J., Li H., Fan G. H., Gu X. Y., Xiao Y., Gao H., Xu J. Y., Yang F., Wang X. M., Wu C., Chen L., Liu Y. W., Liu B., Yang J., Wang X. R., Dong J., Li L., Huang C. L., Zhao J. P., Hu Y., Cheng Z. S., Liu L. L., Qian Z. H., Qin C., Jin Q., Cao B., and Wang J. W., Chin. Med. J. 133(9), 1015–1024 (2020). 10.1097/CM9.0000000000000722 - DOI - PMC - PubMed
    1. Giovanetti M., Benvenuto D., Angeletti S., and Ciccozzi M., J. Med. Virol. 92, 584–588 (2020). - PMC - PubMed